2014/3 GaBI Journal Table of Contents

Contents

Editor’s Letter

Latest features in GaBI Journal, 2014, Issue 3

Editorial

Regional regulatory processes for the approval of biosimilars; differences and similarities

Original Research

Barriers to market uptake of biosimilars in the US

Retrospective chart review: disrupted anaemia control in haemodialysis patients following the switch to an iron sucrose similar (ISS) after long-term treatment with the originator iron sucrose (IS)

Ongoing initiatives to improve prescribing efficiency in China; statins as a case history

GnRH agonists and antagonists in prostate cancer

Review Article

Recommendations for the regulation of biosimilars and their implementation in Latin America

Perspective

Subsequent entry biologics (biosimilars) in Canada: approaches to interchangeability and the extrapolation of indications and uses

Interview

Biosimilars collaboration at Amgen and Actavis

Pharma News

ECCO 2013 survey highlights lack of confidence in biosimilars

Source URL: http://gabi-journal.net/20143-gabi-journal-table-of-contents.html


Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048